Gene: MYCBPAP
Official Full Name: MYCBP associated proteinprovided by HGNC
Gene Summary: Predicted to enable clathrin binding activity and phospholipid binding activity. Involved in spermatogenesis. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25224 | MYCBPAP Knockout cell line (A549) | Human | MYCBPAP | 1:3~1:4 | Negative | Online Inquiry |
MYCBPAP Gene Knockout Cell Lines are a specialized suite of genetically engineered cell lines specifically designed to facilitate the study of MYCBPAP (Myosin-Heavy Chain Binding Protein A), a crucial regulator of various cellular processes including muscle contraction, differentiation, and signaling pathways. These knockout cell lines are created using advanced CRISPR/Cas9 technology, which allows for precise deletion of the MYCBPAP gene, thereby enabling researchers to investigate its role in health and disease, particularly in cardiomyopathies and skeletal muscle disorders.
The primary function of MYCBPAP Gene Knockout Cell Lines is to mimic the genetic ablation of MYCBPAP in various cell types, allowing for detailed investigations into the protein’s biological functions and interactions in vivo. By studying these knockout models, researchers can elucidate the downstream signaling pathways affected by MYCBPAP absence, examine compensatory mechanisms within cells, and identify potential therapeutic targets for intervention in muscle-related diseases. This product is invaluable for both basic and translational research, offering insights into muscle biology that can lead to novel therapeutic strategies.
One of the distinctive advantages of our MYCBPAP Gene Knockout Cell Lines is their high specificity and reproducibility compared to traditional knockdown methods such as RNA interference, which can result in off-target effects. Additionally, our lines are rigorously validated for consistent phenotypic behavior, making them reliable tools for experimental replicability. Another unique selling point is the availability of various cell types, ranging from immortalized cell lines to primary cells, thereby providing flexibility to researchers across multiple disciplines.
For researchers and clinicians working on muscle pathologies, these cell lines represent a powerful and versatile resource to advance understanding and treatment options. The ability to create customized knockout models that specifically meet experimental requirements adds unparalleled value, streamlining and enhancing research productivity.
At our company, we pride ourselves on our commitment to delivering high-quality biological products backed by cutting-edge technology and scientific expertise. Our team of experienced professionals is dedicated to supporting researchers in their quest to unravel the complexities of cellular mechanisms, ensuring that they have the best tools at their disposal for innovative discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.